Twelve-year analysis of severe cases of drug reaction with eosinophilia and systemic symptoms: a cause of unpredictable multiorgan failure.
暂无分享,去创建一个
V. Paradis | O. Chosidow | J. Guillaume | P. Musette | B. Crickx | V. Descamps | B. Milpied | A. Grange | S. Ranger-Rogez | P. Joly | L. Allanore | I. Guillot | Majed Eshki
[1] M. Tohyama,et al. Association of human herpesvirus 6 reactivation with the flaring and severity of drug‐induced hypersensitivity syndrome , 2007, The British journal of dermatology.
[2] P. Schnitzler,et al. Fatal circumstances of human herpesvirus 6 infection: transcriptosome data analysis suggests caution in implicating HHV-6 in the cause of death , 2007, Journal of Clinical Pathology.
[3] Z. Ikezawa,et al. The diagnosis of a DRESS syndrome has been sufficiently established on the basis of typical clinical features and viral reactivations , 2007, The British journal of dermatology.
[4] V. Descamps,et al. Augmentation de la réplication in vitro de l’herpèsvirus humain 6 en présence de valproate de sodium , 2007 .
[5] D. Zerr. Human herpesvirus 6 and central nervous system disease in hematopoietic cell transplantation. , 2006, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
[6] O. Boccara,et al. Association of hypogammaglobulinemia with DRESS (Drug Rash with Eosinophilia and Systemic Symptoms). , 2006, European journal of dermatology : EJD.
[7] M. Seishima,et al. Hypogammaglobulinemia as an early sign of drug-induced hypersensitivity syndrome. , 2006, Journal of the American Academy of Dermatology.
[8] P. Demoly,et al. Variability in the clinical pattern of cutaneous side‐effects of drugs with systemic symptoms: does a DRESS syndrome really exist? , 2006, The British journal of dermatology.
[9] E. Mahé,et al. Systemic Reactions to HHV-6 Infection , 2006 .
[10] G. Krueger,et al. Human herpesvirus-6 : general virology, epidemiology and clinical pathology , 2006 .
[11] T. Shiohara,et al. Drug-induced Hypersensitivity Syndrome(DIHS): A Reaction Induced by a Complex Interplay among Herpesviruses and Antiviral and Antidrug Immune Responses. , 2006, Allergology international : official journal of the Japanese Society of Allergology.
[12] M. Boeckh,et al. Clinical outcomes of human herpesvirus 6 reactivation after hematopoietic stem cell transplantation. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[13] Yuan-Tsong Chen,et al. HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[14] S. Burastero,et al. Viral Replication-Independent Blockade of Dendritic Cell Maturation and Interleukin-12 Production by Human Herpesvirus 6 , 2005, Journal of Virology.
[15] J. Roujeau,et al. Syndrome d’hypersensibilité médicamenteuse ou DRESS (Drug Reaction with Eosinophilia and Systemic Symptoms) , 2004 .
[16] J. Roujeau,et al. [Drug hypersensitivity syndrome: DRESS (Drug Reaction with Eosinophilia and Systemic Symptoms)]. , 2004, Annales de dermatologie et de venereologie.
[17] M. Tohyama,et al. Human herpesvirus 6 and drug allergy , 2003, Current opinion in allergy and clinical immunology.
[18] E. Mahé,et al. Active human herpesvirus 6 infection in a patient with drug rash with eosinophilia and systemic symptoms. , 2003, The Journal of investigative dermatology.
[19] P. Griffiths,et al. Cytomegalovirus, human herpesvirus-6, and human herpesvirus-7 in hematological patients. , 2003, Seminars in hematology.
[20] V. Descamps,et al. Prodynorphin gene promoter polymorphism and temporal lobe epilepsy , 2003, Annals of neurology.
[21] Tatsuo Yamada,et al. Human herpesvirus 6 encephalitis associated with hypersensitivity syndrome , 2002, Annals of neurology.
[22] M. Pirmohamed,et al. TNFα promoter region gene polymorphisms in carbamazepine-hypersensitive patients , 2001, Neurology.
[23] B. Crickx,et al. Association of human herpesvirus 6 infection with drug reaction with eosinophilia and systemic symptoms. , 2001, Archives of dermatology.
[24] P. Vignon,et al. Reactivation of human herpesvirus type 6 in multiple organ failure syndrome. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[25] J. Roujeau,et al. SCORTEN: a severity-of-illness score for toxic epidermal necrolysis. , 2000, The Journal of investigative dermatology.
[26] M. Tohyama,et al. Severe hypersensitivity syndrome due to sulfasalazine associated with reactivation of human herpesvirus 6. , 1998, Archives of dermatology.
[27] D. Descamps,et al. Human herpesvirus 6 infection associated with anticonvulsant hypersensitivity syndrome and reactive haemophagocytic syndrome , 1997, The British journal of dermatology.
[28] L. Hughes-Davies,et al. Severe adverse cutaneous reactions to drugs. , 1995, The New England journal of medicine.
[29] K. Akashi,et al. Brief report: severe infectious mononucleosis-like syndrome and primary human herpesvirus 6 infection in an adult. , 1993, The New England journal of medicine.